A growing population of people with software experience plus an interest in life sciences is boosting drug development in the San Francisco Bay Area, according to panelists at an Xcelerating event.
Innovation in the San Francisco Bay Area may first bring to mind tech behemoths like Facebook and Google. But some drug development companies in the region say its openness to new ideas and the combination of software experience and life sciences expertise are boosting their prospects.
“For us inside the company, having that kind of ‘wet’ and ‘dry’—what Daphne Koller, our founder and CEO, calls that ‘bilingual’—perspective is critically important,”… Read more »
UNDERWRITERS AND PARTNERS
